NIRECO CORPORATION Full-Year Earnings Briefing Flash Report

JPY 2B Capacity Expansion Investment in Optics and Launch of Centennial Vision; Order Backlog +29% Signals an Accelerating Growth Trajectory

PublishedMay 14, 2026 at 19:30 GMT+9

Summary

In FY2026/3, revenue reached JPY 11,022M (a record high), broadly in line with the plan. However, a JPY 184M increase in COGS and a JPY 133M rise in SG&A weighed on profitability, with operating income declining 11% YoY to JPY 1,701M. On the other hand, orders grew double digits across all segments, reaching JPY 12,496M (+19% YoY), while order backlog hit a record JPY 6,637M (+29% YoY). At the briefing, management explicitly committed to a ~JPY 2B capacity expansion investment in the Optics business with a target start of operations in FY2029/3. The medium-term plan targets revenue of JPY 14B and operating income of JPY 2.5B by FY2029/3. Shareholder returns have been enhanced to a payout ratio of 50%+ and DOE of 3%+, with a record-high dividend of JPY 105 per share (including a special dividend) planned for FY2027/3.

Key Points (Earnings Takeaways and Growth Actions)

  • Business Strategy and Market Positioning
    • Clear strategic shift of revenue base from mature industries (steel) to growth sectors such as semiconductors
    • Positioned to capture both high-grade steel investment and CO2 reduction capex from steelmakers
    • Developing new power-generation device markets—perovskite solar cells, all-solid-state batteries—on both the inspection equipment and control equipment fronts
  • Current Business Progress and Drivers
    • The primary drag on operating income was a reversal from high-margin product mix in the prior year, compounded by revenue decline in functional films and flexible packaging
    • The Optics business booked multiple laser system orders and a large optical components order in Q4, driving order backlog up +47% YoY
    • The Inspection Equipment business posted a segment loss of JPY 30M due to sluggish H1 orders, though orders for blank inspection systems and food inspection equipment recovered in H2
  • Strategic Initiatives and Inflection Points
    • Oyo Kogiken Kogyo was made a subsidiary and consolidated from Q4 (revenue contribution: JPY 409M in Inspection Equipment, JPY 226M in Optics)
    • Transitioned to a function-based organizational structure from April 2026, promoting more efficient allocation of management resources
    • Launched five-year plan "NIRECO-VISION 100" ahead of the company's centennial; specific quantitative targets to be disclosed going forward

Outlook and Strategy

  • FY2027/3 plan: Revenue JPY 12,500M (+13%), operating income JPY 1,900M (+12%). Premised on full-year contribution from Oyo Kogiken and drawdown of the elevated order backlog
  • The medium-term plan targets revenue of JPY 14,000M and operating income of JPY 2,500M by FY2029/3, with additional upside from M&A earmarked separately
  • The JPY 2B Optics capacity expansion investment is to be finalized and commenced this fiscal year, with operations targeted for FY2029/3. Funded through a combination of internal cash and debt
  • Accelerating global expansion into growth markets such as the US and India through collaboration with Germany's IMS Group
  • In the Inspection Equipment business, advancing surface inspection technology development for next-generation power generation methods including perovskite solar cells
  • The medium-term plan is scheduled for review within six months in line with the progress of the NIRECO-VISION 100 project

Positive Factors

  • Orders of JPY 12,496M (+19% YoY) and order backlog of JPY 6,637M (+29% YoY), with double-digit growth across all segments—providing high visibility into next fiscal year's earnings
  • The DUV laser market for semiconductor inspection, a key driver for the Optics business, is projected to grow at a CAGR of 10.1% (reaching USD 65M by 2030)
  • Kogaku Giken is the only company capable of commercial processing of CLBO crystals; Oyo Kogiken holds the top domestic market share in NaI(Tl) scintillator crystals
  • Enhanced shareholder returns with payout ratio raised to 50%+ and DOE to 3%+; FY2027/3 dividend of JPY 105 per share (a record high)
  • Domestic market leader in control and marking equipment for the steel sector, as well as in edge position control devices and glue inspection equipment
  • Record-high FCF of JPY 2,638M; equity ratio of 82.9% underpins a solid financial foundation

Concerns / Risks

  • OPM declined 2.3pp from 17.7% to 15.4%; absorbing rising costs and SG&A remains an ongoing challenge
  • The Inspection Equipment business has posted segment losses of JPY 30M for two consecutive years. A return to profitability at JPY 200M is planned for FY2027/3 but requires confirmation through actual results
  • The full-year plan does not factor in direct impacts from US tariff policy or Middle East geopolitical developments, leaving downside exposure should these risks materialize
  • The JPY 2B Optics capacity expansion investment amount has not been finalized due to construction cost volatility; risk of cost overruns warrants attention
  • Stagnation in the secondary battery market could delay a revenue recovery in the functional films and flexible packaging segment
  • Semiconductor cycle fluctuations pose order volatility risk for the Optics business

Performance Highlights

FY2026/3 revenue reached a record high of JPY 11,022M (+2% YoY). Operating income declined 11% YoY to JPY 1,701M, though net income attributable to owners of parent company came in at JPY 1,441M—the second-highest level on record. Order backlog of JPY 6,637M (+29% YoY) provides a structural underpinning for top- and bottom-line growth in the coming fiscal year.

Segment Performance

SegmentRevenueYoYSegment IncomeYoY
Control EquipmentJPY 5,758M▲1%JPY 1,398M▲10%
Inspection EquipmentJPY 1,904M+20%JPY ▲30M
OpticsJPY 2,854M▲2%JPY 1,024M▲4%
  • Orders: JPY 12,496M (+19% YoY)
  • Order Backlog: JPY 6,637M (+29% YoY)
  • Operating Income Margin: 15.4% (prior year: 17.7%)
  • EPS: JPY 196.75 (▲7% YoY)
  • Annual Dividend: JPY 89 (prior year: JPY 95; raised JPY 4 from the initial forecast of JPY 85)
  • Free Cash Flow: JPY 2,638M (prior year: JPY 978M)
  • Consolidated Headcount: 533
Disclaimer

Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

  • Purpose and Disclaimer Regarding Investment Decisions

    This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.

  • Information Sources, Accuracy, and Disclaimer of Warranty

    This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.

  • Limitation of Liability

    Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.

  • Potential Conflicts of Interest

    Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.

  • No Obligation to Change or Update Content

    The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.

  • Governing Language

    This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.

  • Copyright

    All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.

  • Use for Other Investment Products

    Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.